Premium
Acral lentiginous melanoma: an immunohistochemical study of 20 cases
Author(s) -
Kim You Chan,
Lee Min Geol,
Choe Sung Whan,
Lee Mn Cheol,
Chung Han Gil,
Cho SangHo
Publication year - 2003
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1046/j.1365-4362.2003.01583.x
Subject(s) - immunohistochemistry , medicine , melanoma , hmb 45 , acral lentiginous melanoma , pathology , vimentin , s100 protein , melanin , antibody , biology , cancer research , immunology , genetics
Background Though acral lentiginous melanoma (ALM) is a major type of malignant melanoma, no immunohistochemical study on this type of melanoma has been reported. Objective The purpose of this study is to analysis the immunohistochemical findings of ALM using routinely used immune markers. Methods An immunohistochemical study was performed on paraffin sections of 20 ALMs using S‐100 protein, HMB‐45, MART‐1, vimentin, epithelial membrane antigen (EMA) and CAM 5.2. Results S‐100 protein (95%) was found to be a more sensitive marker than either HMB‐45 (80%) or MART‐1 (70%) for recognizing ALM. Melanin bleaching was useful for recognizing heavily pigmented ALM using both S‐100 protein and HMB‐45. The intensity of HMB‐45 correlated well with the melanin content. However, there was no significant correlation between the intensity of S‐100 protein and the melanin content. One and two out of 20 cases stained focally with EMA and CAM5.2, respectively, but these cases stained also with HMB‐45 and/or S‐100 protein. Conclusions S‐100 protein and HMB‐45 were relatively sensitive markers for recognizing ALM. Despite the occasional positivity for the epithelial markers in ALM, all epithelial marker‐positive cases stained also with HMB‐45 and/or S‐100 protein. Therefore, we recommend that the panel of antibodies used for recognizing ALM should contain at least S‐100 protein and HMB‐45.